Ident. | Authors (with country if any) | Title |
---|
000530 (2017) |
Amy Maxmen | Global coalition chips away at neglected tropical diseases. |
000662 (2017) |
Molly A. Brady [États-Unis] ; Rachel Stelmach [États-Unis] ; Margaret Davide-Smith [États-Unis] ; Jim Johnson [États-Unis] ; Bolivar Pou [États-Unis] ; Joseph Koroma [États-Unis] ; Kingsley Frimpong [Ghana] ; Angela Weaver [États-Unis] | Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis |
000A11 (2016) |
Hugo C. Turner [Royaume-Uni] ; Alison A. Bettis [Royaume-Uni] ; Brian K. Chu [États-Unis] ; Deborah A. Mcfarland [États-Unis] ; Pamela J. Hooper [États-Unis] ; Eric A. Ottesen [États-Unis] ; Mark H. Bradley [Royaume-Uni] | The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014) |
000C43 (2016) |
| Preventive chemotherapy for helminth diseases: progress report, 2014. |
000F79 (2016) |
Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie] | Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys. |
001033 (2016) |
| Global programme to eliminate lymphatic filariasis: progress report, 2015. |
001578 (2015) |
Laura Prieto-Pérez [Espagne] ; Juan José Soriano Cea [Espagne] ; Miguel G Rgolas Hernández-Mora [Espagne] | [Podoconiosis, a society and medical community neglected disease]. |
001613 (2015) |
Randee J. Kastner [Suisse] ; Christopher M. Stone [Suisse] ; Peter Steinmann [Suisse] ; Marcel Tanner [Suisse] ; Fabrizio Tediosi [Suisse] | What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs |
001C05 (2015) |
Jean-Phillip Okhovat [États-Unis] ; Afsaneh Alavi [Canada] | Lipedema: A Review of the Literature. |
002061 (2015) |
Rita M. Dewi [Indonésie] ; Sekar Tuti [Indonésie] ; Sitti Ganefa [Indonésie] ; Chairiyah Anwar [Indonésie] ; Ria Larasati [Indonésie] ; Endah Ariyanti [Indonésie] ; Herty Herjati [Indonésie] ; Molly Brady [États-Unis] | Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of ‘transmission assessment surveys’ (TAS) for the lymphatic filariasis elimination program |
002126 (2015) |
Sören L. Becker ; Thomas Fürst [Royaume-Uni] ; David G. Addiss [États-Unis] ; Jürg Utzinger [Suisse] | Assessing numbers and faces: a prerequisite for improving access to lymphatic filariasis morbidity care. |
002272 (2015) |
| 489 Global programme to eliminate lymphatic filariasis: progress report, 2014. |
002420 (2014) |
Jorge Cano [Royaume-Uni] ; Maria P. Rebollo [États-Unis, Royaume-Uni] ; Nick Golding [Royaume-Uni] ; Rachel L. Pullan [Royaume-Uni] ; Thomas Crellen [Royaume-Uni] ; Anna Soler [Royaume-Uni] ; Louise A Kelly- Hope [Royaume-Uni] ; Steve W. Lindsay [Royaume-Uni] ; Simon I. Hay [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni] ; Simon J. Brooker [Royaume-Uni] | The global distribution and transmission limits of lymphatic filariasis: past and present |
002636 (2014) |
K. D. Ramaiah [Inde] ; Eric A. Ottesen [États-Unis] | Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease |
002744 (2014) |
Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. Taylor | Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience. |
002A42 (2014) |
| Global programme to eliminate lymphatic filariasis: progress report, 2013. |
002D34 (2014) |
Pamela J. Hooper [États-Unis] ; Brian K. Chu [États-Unis] ; Alexei Mikhailov [Suisse] ; Eric A. Ottesen [États-Unis] ; Mark Bradley [Royaume-Uni] | Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis |
003040 (2013) |
B. Nandha [Inde] ; K. Krishnamoorthy ; P. Jambulingam | Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India. |
003410 (2013) |
| Meeting of the International Task Force for Disease Eradication – November 2012. |
003606 (2013) |
| Global programme to eliminate lymphatic filariasis: progress report for 2012. |
003607 (2013) |
David G. Addiss | Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion” |
003711 (2013) |
Donald R. Hopkins [États-Unis] | Disease eradication. |
003728 (2013) |
Fabrizio Tediosi [Suisse] ; Peter Steinmann [Suisse] ; Don De Savigny [Suisse] ; Marcel Tanner [Suisse] | Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges |
003D87 (2012) |
| Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. |
004273 (2012) |
| Global programme to eliminate lymphatic filariasis: progress report, 2011. |
004573 (2012) |
Katherine Gass [États-Unis] ; Madsen V. E. Beau De Rochars [Haïti] ; Daniel Boakye [Ghana] ; Mark Bradley [Royaume-Uni] ; Peter U. Fischer [États-Unis] ; John Gyapong [Ghana] ; Makoto Itoh [Japon] ; Nese Ituaso-Conway [Tuvalu] ; Hayley Joseph [Australie] ; Dominique Kyelem [États-Unis] ; Sandra J. Laney [États-Unis] ; Anne-Marie Legrand [Polynésie française] ; Tilaka S. Liyanage [Sri Lanka] ; Wayne Melrose [Australie] ; Khalfan Mohammed ; Nils Pilotte [États-Unis] ; Eric A. Ottesen [États-Unis] ; Catherine Plichart [Polynésie française] ; Kapa Ramaiah [Inde] ; Ramakrishna U. Rao [États-Unis] ; Jeffrey Talbot [États-Unis] ; Gary J. Weil [États-Unis] ; Steven A. Williams [États-Unis] ; Kimberly Y. Won [États-Unis] ; Patrick Lammie [États-Unis] | A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis |
004D37 (2011) |
| Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. |
004D63 (2011) |
| Lymphatic filariasis. |
004E60 (2011) |
| Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010. |
005585 (2010) |
Brian K. Chu [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Deborah A. Mcfarland [États-Unis] ; Eric A. Ottesen [États-Unis] | The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007) |
005880 (2010) |
Martin Enserink | Global public health. What's next for disease eradication? |
005881 (2010) |
| Global programme to eliminate lymphatic filariasis. |
005883 (2010) |
David G. Addiss | Global Elimination of Lymphatic Filariasis: Addressing the Public Health Problem |
005924 (2010) |
Moses J. Bockarie [Royaume-Uni] ; Rinki M. Deb | Elimination of lymphatic filariasis: do we have the drugs to complete the job? |
005F77 (2009) |
M N Malecela [Tanzanie] ; U. Mwingira ; M E Mwakitalu ; C. Kabali ; E. Michael ; C D Mackenzie | The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road. |
006005 (2009) |
P J Hooper [États-Unis] ; M H Bradley ; G. Biswas ; E A Ottesen | The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007). |
006009 (2009) |
P. Brantus [France] | Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. |
006194 (2009) |
C D Mackenzie [États-Unis] ; W M Lazarus ; M E Mwakitalu ; U. Mwingira ; M N Malecela | Lymphatic filariasis: patients and the global elimination programme. |
006264 (2009) |
| Global programme to eliminate lymphatic filariasis. |
006265 (2009) |
K M Gustavsen [États-Unis] ; M H Bradley ; A L Wright | GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. |
006425 (2009) |
A D Hopkins ; D H Molyneux | A decade of ivermectin-albendazole donation for lymphatic filariasis. |
006440 (2009) |
David H. Molyneux [Royaume-Uni] | 10 years of success in addressing lymphatic filariasis. |
006657 (2009) |
Natalia Mendoza ; Alexa Li ; Amber Gill ; Stephen Tyring [États-Unis] | Filariasis: diagnosis and treatment |
006915 (2008) |
Eric A. Ottesen [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark Bradley [Royaume-Uni] ; Gautam Biswas [Suisse] | The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years |
006A25 (2008) |
| Meeting of the International Task Force for Disease Eradication - 11 October 2007. |
006A45 (2008) |
Malcolm Dean | Lymphatic filariasis has been eliminated in 16 countries, monitoring indicates. |
006B02 (2008) |
| Global programme to eliminate lymphatic filariasis. |
006B03 (2008) |
Edwin Michael [Royaume-Uni] ; Mwele N. Malecela [Tanzanie] ; Mihail Zervos [Royaume-Uni] ; James W. Kazura [États-Unis] | Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes |
006B72 (2008) |
| Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007. |
006C47 (2008) |
Peter J. Hotez [États-Unis] ; David H. Molyneux [Royaume-Uni] ; Alan Fenwick [Royaume-Uni] ; Lorenzo Savioli [Suisse] ; Tsutomu Takeuchi [Japon] | A Global Fund to Fight Neglected Tropical Diseases: Is the G8 Hokkaido Toyako 2008 Summit Ready? |
007153 (2007) |
Gail Davey [Éthiopie] ; Melanie Newport | Podoconiosis: the most neglected tropical disease? |